Skip to main content
ISO 10993-19 Complete Self-Assessment

ISO 10993-19 Complete Self-Assessment

$359.00
Availability:
Downloadable Resources, Instant Access
Adding to cart… The item has been added

What does the ISO 10993-19 Complete Self-Assessment include?

The ISO 10993-19 Complete Self-Assessment includes 617 clause-specific assessment questions mapped to ISO 10993-19:2023, organised across 7 scientific domains, plus an Excel-based dashboard with automated scoring and heatmaps, a 142-page PDF User Guide, and over 60 total files including implementation playbooks, audit templates, RACI charts, and a 90-day roadmap. All files are delivered by email within 24 business hours in a structured digital folder containing PDF and XLSX formats for immediate use.

Are you risking regulatory rejection, delayed market access, or expensive post-submission remediation because your ISO 10993-19:2023 compliance assessment lacks rigour, structure, or traceability? Without a comprehensive, clause-specific self-assessment system aligned to the full scope of ISO 10993-19:2023 - the international standard for nanomaterial-containing medical devices - your team could overlook critical toxicokinetic, immunotoxicological, or physicochemical evaluation requirements, leading to non-conformities during audits by the FDA, EU MDR notified bodies, or Health Canada. The ISO 10993-19 Complete Self-Assessment delivers a fully validated, expert-structured framework that enables you to proactively identify, document, and resolve compliance gaps across all 7 scientific and technical domains of nanomaterial risk evaluation, ensuring your biocompatibility dossier is complete, defensible, and audit-ready from day one.

What You Receive

  • 617 ISO 10993-19:2023-specific assessment questions (XLSX), organised across 7 scientific maturity domains, physicochemical characterisation, hazard identification, dose-response assessment, risk characterisation, exposure assessment, lifecycle considerations, and uncertainty analysis, each mapped directly to applicable clauses in ISO 10993-19:2023, enabling you to conduct a clause-by-clause compliance audit and pinpoint missing evidence or justification in under 30 minutes
  • Excel-based Self-Assessment Dashboard with automated scoring and visual heatmaps (XLSX), featuring built-in calculators, risk-priority matrices, and gap analysis outputs that generate professional, shareable reports for internal review or regulatory submission, reducing manual effort and eliminating scoring errors
  • Comprehensive User Guide eBook (PDF, 142 pages), providing step-by-step workflows, evidence collection checklists, and scientific decision logic for every assessment question, so you know exactly what data to gather, how to interpret results, and how to justify conclusions to auditors or notified bodies
  • 00_Platinum_Tier Master Playbook (PDF), including a 90-day ISO 10993-19 implementation roadmap, a biocompatibility risk assessment template, an uncertainty analysis decision matrix, and an audit defence runbook, giving you a clear, structured path from assessment to submission
  • 02_Self_Assessment_and_Diagnostics section with 7 domain-specific gap analysis worksheets (XLSX/PDF), enabling granular scoring of current maturity levels and targeted remediation planning
  • 03_Requirements_and_Goal_Setting templates (XLSX), including stakeholder alignment matrices and regulatory goal trackers, so you can align cross-functional teams around compliance priorities and submission timelines
  • 04_Models_and_Frameworks tools (PDF/XLSX), featuring comparison matrices for nanomaterial categorisation, decision trees for testing waivers, and lifecycle risk models that align with ISO 14971, ensuring your assessment is both scientifically rigorous and risk-managed
  • 06_Processes_and_Execution playbooks (PDF, 15 files), including RACI templates for toxicology reviews, interview scripts for CROs, and documentation workflows that streamline evidence collection across R&D, QA, and regulatory affairs
  • 08_Quality_and_Governance resources (PDF/XLSX), such as audit preparation checklists, non-conformance response plans, and policy templates, so you can demonstrate regulatory due diligence and governance oversight
  • Full digital playbook delivery via email within 24 business hours, no waiting, no login portals, containing all 60+ files (38 XLSX, 23 PDF) in a logically structured folder hierarchy with README.md and CUSTOMER_EMAIL.txt onboarding notes for instant access and use

How This Helps You

This Self-Assessment equips you to transform an otherwise complex, high-risk compliance process into a structured, evidence-driven workflow that prevents costly oversights. By systematically addressing all 617 requirements across ISO 10993-19’s seven domains, you eliminate ambiguity in nanomaterial risk evaluation, reduce reliance on external consultants, and accelerate your internal review cycles. The automated dashboards let you generate defensible, visual compliance reports for auditors in minutes, not weeks, while the Platinum Tier roadmap ensures you maintain momentum from initial assessment to final dossier submission. Without this tool, you risk incomplete submissions, regulatory queries, or rejected approvals, each of which can delay time-to-market by 6-12 months and cost hundreds of thousands in retesting and resubmission. With it, you gain confidence, control, and compliance certainty.

Who Is This For?

  • Medical device regulatory affairs managers preparing biocompatibility dossiers for FDA 510(k), PMA, or EU MDR submissions involving nanomaterials
  • Biomaterials scientists and toxicologists responsible for evaluating nanomaterial safety and justifying testing strategies
  • Quality assurance and compliance leads conducting internal audits or preparing for notified body inspections
  • R&D project managers overseeing development of nanotechnology-based devices such as drug delivery systems, nanocoated implants, or nanosensors
  • Consultants and CROs supporting clients with ISO 10993-19 compliance and seeking standardised, repeatable assessment frameworks

Purchasing the ISO 10993-19 Complete Self-Assessment isn’t just a resource acquisition, it’s a strategic decision to de-risk your regulatory pathway, strengthen scientific defensibility, and ensure your nanomaterial-containing medical device meets the highest global standards for biocompatibility evaluation. This is the system trusted by leading medtech organisations to close compliance gaps fast and submit with confidence.

!